Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seems it held pretty well against lower volume..
Finally geting that post lunchtime uptick back after that "Supersized Crystal burger" ... Way funny B/R..
Lunchtime Lull..
Don't forget to lock your shares with a high ask price to keep them from being able to "Cover" ..
Nice Spike ...
I was impressed that the Bedford reports focused on SAPX considering their agenda to be growth, strong potential, etc. etc. I would assume they do "Dig Deeper" DD...
Didn't sound that bad to me..
Interesting..What stage of this"wave"do you see SAPX in?
Man, after that post i'm out..at least it was from .0733 and not .2733 : ) GLT Yall... I'll be keeping a watch anyway...
Just like moving money $9999.99@a time.Avoid complications?
So that's it then??Just another tanking Scam??
This is obviously tanking.Morbid fascination keeps me looking..
Seen 02's on the bid but any actually sold?
And again to .83?? that's crazy.Wot Happened?
I'm freakin'.. what happened?? 25% down???
That would be the $64,000 Question :)
And Still Broke.. Post R/S with the prices way back down now it sure seems to look like a great time to accumulate some shares if any will let loose at these bid prices ...
You called that shorting candidate like a Pro...
TechniScan Elects Joe Pepper, Ph.D. as Chairman of the Board
SALT LAKE CITY (December 15, 2010) -- TechniScan (OTC Bulletin Board: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, announced that Joe Pepper, Ph.D. has been elected as chairman of the board of directors of TechniScan.
“As a member of the current board of directors, Joe Pepper has already made significant contributions in helping us bring TechniScan's Warm Bath Ultrasound closer to commercialization, and his leadership and experience in the field will further benefit the company as he takes over as the chairman," said outgoing Board Chairman Ken Hungerford.
Hungerford has served as chairman since the company went public in the fall of 2009, and he will continue to serve on the board’s executive committee along with Pepper and TechniScan CEO David Robinson.
With 28 years in the medical device field, Pepper currently serves as a consultant to medical device start-ups. Formerly he served as CEO of U-Systems, Inc., a privately-backed start-up that developed automated ultrasound for the early detection of breast cancer in women with dense breast tissue. He was CEO for OEC Medical Systems, a NYSE-traded, mobile fluoroscopic imaging equipment manufacturer until it was sold to GE Healthcare. He spent 15 years with The BOC Group, Plc., where he served as president of its subsidiary Ohmeda Medical Devices, which was responsible for international selling and distribution of medical devices, and as president of Ohmeda Medical Equipment.
Pepper has been a member of TechniScan’s board of directors since October 2009. He has a BS/MS in Engineering Science from Florida State University, a Ph.D. in Mechanical Engineering from Stanford University and an MBA from The Harvard Business School.
"I am excited about the opportunity to add my knowledge and perspective to TechniScan, a company I have admired for quite some time. Its 3D ultrasound images have impressive specificity and the potential to change the way that radiologists and oncologists detect cancer in the breast. The TechniScan management team has outstanding depth and diversity of perspective. I am honored to be a part of the group, and I feel confident that with our collective experience, we can make TechniScan’s imaging modality the premier method for breast diagnostics,” said Pepper.
“It’s a pleasure to be working with a person of Joe’s professional caliber and look forward to working to effectively execute our business plan with him,” Robinson said.
TechniScan and its 3D breast ultrasound technology , will be featured at 2010 Southern California Investors Conference
SALT LAKE CITY (August 16, 2010) – TechniScan (OTC BB: TSNI), the developer of a novel warm bath, 3D breast diagnostic imaging system today announced that it will be a presenter at the 2010 Southern California Investor Conference.
Dave Robinson, chief executive officer for TechniScan will be presenting a market overview for breast imaging, the unique attribute’s of TechniScan’s Warm Bath Ultrasound system, and the company’s strategy to take the product to the commercial medical market.
In its 15th year, the Southern California Investor Conference highlights the wealth of growth companies located in the Southern California region including world recognized life science, technology, media and real estate/financial companies. Officers from 30 of Southern California's leading companies will present corporate updates and business insights to the investment community.
The conference is being held at the Island Hotel in Newport Beach on Tuesday, August 17. TechniScan will be presenting in Cabana room 4 at 2 pm WDT.
Yeah , this is killing me ... i'm broke : (
TechniScan’s warm bath 3D breast imaging device featured as top emerging medical technology
CEO says the demand for breast diagnostics will grow with aging baby boomers
SALT LAKE CITY (August 11, 2010) – TechniScan (OTC BB: TSNI), was among the 25 top emerging medical technology companies featured today on Life Science Intelligence’s (LSI) investor presentation.
This online venue provides a timely release of the most promising emerging medical technology companies identified by LSI. The event provides detailed information on a select group of companies, including presentations (audio and slides), executive summaries, fund raising status, partnering status, and much more.
“This presentation places TechniScan and our warm bath, 3D breast imaging device among some of the most promising private and public medical technology companies today. It is a comprehensive and informative venue for investors to evaluate the latest technologies that have the potential to change the future of medicine,” said Dave Robinson, chief executive officer for TechniScan.
TechniScan’s warm bath, 3D breast imaging device is designed to capture three-dimensional images of the breast as a woman lies prone on a table and state-of-the-art ultrasound technology is used in a warm water tank to image the breast anatomy. Its revolutionary new method of imaging produces information and whole breast images that are not available with traditional reflection ultrasound or whole breast ultrasound systems presently on the market.
With the aging baby boomer population, the market segment for breast screening and diagnostic devices is expected to grow by 1.5 percent each year over the next twenty years. According to the National Cancer Institute, the highest percentage of breast cancer is found in women over the age of 65.
“Strictly considering the demographic growth projections for breast screening and diagnostics, there is a built in demand for our device. Couple this with the desire from women and radiologists for comfortable and more sophisticated tools to more accurately diagnose breast cancer, and we are very confident in the demand for our 3D breast imaging system,” said Robinson.
Unique to the ultrasound market, TechniScan’s revolutionary science employs transmission ultrasound in addition to standard reflection ultrasound to form its high-resolution, compounded 360-degree view of the breast in a natural uncompressed condition. The technology in protected by multiple patents.
Life Science Intelligence (LSI) delivers high quality market data and information to medical technology executives, entrepreneurs and investors. LSI produces its own information products and partners with select top tier information companies to distribute their high-end information.
To view today’s investor presentation, go to www.lifescienceintelligence.com and select EMT Spotlight and “register to attend.” The presentations will be archived on the LSI website. You can also call LSI at 1-714-847-3540.
TechniScan, Inc. Announces One-for-Four Reverse Stock Split
Stock Will Begin Trading on a Split-Adjusted Basis on June 28, 2010
SALT LAKE CITY (June 24, 2010) – TechniScan (OTC BB: TSNI), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced it filed a certificate of amendment to implement a one-for-four reverse stock split of the company’s issued and outstanding common stock.
The reverse stock split, which was previously approved by the company’s board of directors and stockholders, will take effect with the opening of the markets on Monday, June 28, 2010, subject to approval by FINRA. Trading of TechniScan’s common stock will continue on a reverse stock split-adjusted basis.
The board believes that the reverse stock split will increase market price, help attract long term investors and increase investor interest. The increase in stock price will also allow the company to meet the requirements to be accepted to the American Stock Exchange (AMEX), should the company pursue an application for such listing.
TechniScan stockholders will receive one new TechniScan share for every four shares that they held prior to the split, and all fractional shares will be rounded up to the next whole share on a certificate basis only. As a result of the reverse stock split, the number of shares of the company’s common stock outstanding will be reduced from approximately $82.9 million to approximately $20.7 million shares.
To indicate that the reverse stock split has occurred, a “D” will be added to the company’s trading symbol, such that the post-split common stock will trade under the symbol “TSNID” beginning on June 28, 2010 for a period of 20 trading days, after which TechniScan’s common stock will resume trading under the symbol “TSNI.” The new CUSIP number for the company’s post-split common stock will be 87855G 206.
TechniScan announces adding another center to worldwide clinical trials for new breast imaging system
Announces preliminary clinical results and evaluations
SALT LAKE CITY (June 16, 2010) – TechniScan, (OTC BB: TSNI) a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, today announced that it has launched a clinical study in Rochester, Minn., its third new clinical site to commence in the last five months.
TechniScan’s Warm Bath Ultrasound (WBU) system is designed to capture three-dimensional images of the breast as a woman lies prone on a table and state-of-the-art ultrasound technology is used in a warm water tank to image the breast anatomy. Its revolutionary new method of imaging produces information and whole breast images that are not available with traditional reflection ultrasound or whole breast ultrasound systems presently on the market.
To date, TechniScan has scanned over 800 women in clinical studies in Salt Lake City and Ogden, Utah as well as Orange and San Diego, California. These past clinical studies focused on key factors like image quality, repeatability, and establishing protocols for testing baseline values for positive and negative predictive capabilities of the system.
According to Dr. John Klock, TechniScan's chief medical officer, the most recently completed clinical work continues to support that refraction-corrected reflection images highlight connective tissue features within the breast, whereas the speed-of-sound images show fibroglandular, ductal and terminal lobular units with high resolution.
Image consistency and reproducibility, whether it is weeks, months or a year between exams, are critical to support precise and reliable assessment of breast lesions. Clinical studies in San Diego recently evaluated the ability of the system to reliably reproduce images from the same woman.
"We have clearly demonstrated that the system can reliably reproduce images based on reflection and sound transmission and that those images will have significant clinical utility," said David Robinson TechniScan's president and CEO.
“Volumetric whole-breast imaging provides a substantial practical advantage over conventional very-small-field-of-view sonography. We are greatly aided by the ability to produce repeatable whole-breast comparisons – left to right and present to past. These comparisons are the nuts and bolts of breast imaging, by any modality,” said Michael Andre, Ph.D., adjunct professor of radiology and director of medical physics at University of California, San Diego School of Medicine.
Building on this prior clinical work, the current clinical studies in Freiberg, Germany, San Diego and Rochester will involve at least 500 women with various types of breast lesions. Major objectives of the 12-month study will be to compare WBU to conventional breast sonography and MRI as well as to examine the WBU system’s ability to differentiate between normal, benign and malignant breast tissue. These clinical studies in the U.S. are funded by a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute.
TechniScan’s current study sites include the University Medical Center Freiburg in Germany, Moores UCSD Cancer Center, and the latest clinical study site in Rochester, Minnesota as well as limited imaging studies that support product development in Genoa, Italy and Salt Lake City, Utah.
“Overall we expect to image another 600 or more patients in our clinical program over the next 6-12 months,” said Robinson. “These studies will provide us with critical information about the clinical utility and application of the WBU capabilities.”
“The feedback that we are receiving from our scientists and radiologists at our study sites gives us good reasons to remain cautiously optimistic,” said Klock.
Researchers involved in the studies will also utilize TechniScan’s groundbreaking imaging network, which provides them with the ability to archive, store, and retrieve WBU images and relevant medical records and to collaborate with other research sites.
“Our vision is to begin to create a database of thousands of breast images as well as the underlying and related image data,” said Robinson. “With complete anonymity, women can contribute their mammograms, breast MRIs and WBU images along with related pathology and other information to provide researchers around the world an unprecedented opportunity to study breast cancer. TechniScan’s imaging network will also allow timely and efficient collaboration of patient’s records for her medical team’s use. The concept is simple, yet revolutionary within the medical system and represents a key competitive advantage of the TechniScan system.”
Hate to be repetitious but if people would lock their shares by putting in a sell order on them then those shares wouldn't be available for the short sellers to manipulate and it would put the squeeze on them ...
Lock your shares from use for shorting by putting in a high sell order as soon as you buy them... continued buying is great but if they're free to manipulate the shares that you own because they are not locked into a sell then the MM's can continue to utilise them for their own agenda...
Please enlighten.. What does this mean for a company's stock ??
The company today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission
for a best efforts offering of a minimum of 16,000,000 units and a maximum of 28,500,000 units.
Each unit consists of one share of common stock and one warrant to purchase 0.4 shares of common stock. It is also registering shares of its common stock for sale by certain selling stockholders (as identified in a separate prospectus) outside of the units offering.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
They will hold a special meeting of stockholders on Friday, at their offices . The purpose of the special meeting is to approve an amendment to the company’s Certificate of Incorporation to effect a 1-for-4 reverse stock split of the issued and outstanding common stock. The number of the company’s authorized shares of common stock will remain 150,000,000 and will not be proportionally reduced.
Please enlighten.. What does this mean for a company's stock ??
The company today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a best efforts offering of a minimum of 16,000,000 units and a maximum of 28,500,000 units.
Each unit consists of one share of common stock and one warrant to purchase 0.4 shares of common stock. It is also registering shares of its common stock for sale by certain selling stockholders (as identified in a separate prospectus) outside of the units offering.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
They will hold a special meeting of stockholders on Friday, at their offices . The purpose of the special meeting is to approve an amendment to the company’s Certificate of Incorporation to effect a 1-for-4 reverse stock split of the issued and outstanding common stock. The number of the company’s authorized shares of common stock will remain 150,000,000 and will not be proportionally reduced.
TechniScan Announces Special Meeting of Stockholders
SALT LAKE CITY (June 9, 2010) -- TechniScan (OTC BB: TSNI) a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, will hold a special meeting of stockholders on Friday, June 18, 2010 at 10:00 a.m. MDT at the company’s offices located at 3216 South Highland Drive, Suite 200, Salt Lake City, Utah 84106.
The purpose of the special meeting is to approve an amendment to the company’s Certificate of Incorporation to effect a 1-for-4 reverse stock split of the issued and outstanding common stock. The number of the company’s authorized shares of common stock will remain 150,000,000 and will not be proportionally reduced.
TechniScan Files Registration Statement for Public Offering of its Equity
SALT LAKE CITY (June 3, 2010) -- TechniScan, Inc. (OTC BB: TSNI) a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a best efforts offering of a minimum of 16,000,000 units and a maximum of 28,500,000 units.
Each unit consists of one share of common stock and one warrant to purchase 0.4 shares of common stock. TechniScan is also registering shares of its common stock for sale by certain selling stockholders (as identified in a separate prospectus) outside of the units offering.
Jesup & Lamont Securities Corp. and Global Hunter Securities LLC will act as placement agents for the units offering but not for the shares of common stock to be sold by the selling stockholders.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be a sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
When available, copies of the preliminary prospectus relating to the offering may be obtained from Jesup & Lamont Securities Corp., 110 East 59th Street - 37th Floor
New York, NY 10022 or by calling Mark Diamond (212) 918-0415.
What is the website for penny pick pro ??
What is the website for penny pick pro ??
still 3 mil short of half of yesterdays volume but still early enough in the day ...
Wish I could have afforded 2 mil around that price as this will run right through the 7's with the next big stir..
Nope .. avg .0053
Uptick@.0039 Bid.004 Ask.0044
At what .. .004 ??
Seeing uptick now .. B-.0039 A-.0042 : )
OK HotStockAce.. throw my meager 88250 into the pool as locked and waiting...
Sounds like some serious loan interest getting charged at our expense.. who would borrow money at 50 to 1 and better .. has to be some relatives or friends involved in that deal somehow ...